» Articles » PMID: 16516535

Pathogenic Superoxide Dismutase Structure, Folding, Aggregation and Turnover

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2006 Mar 7
PMID 16516535
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Significant advances have been made during the past two years toward an understanding of the molecular basis for how mutations in human cytosolic copper-zinc superoxide dismutase (SOD1) cause the inherited form of amyotrophic lateral sclerosis (ALS). Biophysical studies suggest that the pathogenic mutations destabilize loop or beta-barrel structural elements of the protein. With few exceptions, the loss of metal ions and reduction of the intrasubunit disulfide bond enhance this destabilization. In mouse models of the disease, the formation of visible aggregates containing mutant SOD1 occurs relatively late in the lifespan, hinting that the quality control and protein turnover systems of motor neurons eventually become overwhelmed or compromised. Studies probing SOD1 turnover have suggested the possibility that proteolytic breakdown products may play a role in pathogenesis.

Citing Articles

Association study between superoxide Dismutases gene polymorphisms and development of diabetic retinopathy and cataract in Iranian patients with type two diabetes mellitus.

Saremi L, Taghvaei S, Feizy F, Ghaffari M, Babaniamansour S, Saltanatpour Z J Diabetes Metab Disord. 2021; 20(1):627-634.

PMID: 34178856 PMC: 8212287. DOI: 10.1007/s40200-021-00790-7.


Copper ion / HO oxidation of Cu/Zn-Superoxide dismutase: Implications for enzymatic activity and antioxidant action.

Tiwari M, Hagglund P, Moller I, Davies M, Bjerrum M Redox Biol. 2019; 26:101262.

PMID: 31284117 PMC: 6614508. DOI: 10.1016/j.redox.2019.101262.


Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.

Lee J, Liu J, Lin S, Harn H, Chiou T Cell Transplant. 2018; 27(9):1301-1312.

PMID: 30033758 PMC: 6168987. DOI: 10.1177/0963689718785154.


FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy.

Funikov S, Rezvykh A, Mazin P, Morozov A, Maltsev A, Chicheva M Neurogenetics. 2018; 19(3):189-204.

PMID: 29982879 DOI: 10.1007/s10048-018-0553-9.


Transfer of pathogenic and nonpathogenic cytosolic proteins between spinal cord motor neurons in vivo in chimeric mice.

Thomas E, Fenton W, McGrath J, Horwich A Proc Natl Acad Sci U S A. 2017; 114(15):E3139-E3148.

PMID: 28348221 PMC: 5393223. DOI: 10.1073/pnas.1701465114.